drugset / Trial / NCT02408744
Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease
Phase 1/2
Completed
30 enrolled
University of Guadalajara
Cell Therapy And Technology, S.a. De C.v. · collab
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study was to evaluate the impact in safety and efficacy of a new formulation of prolonged-released Pirfenidone in the progression of renal damage in patients with Chronic kidney Disease (CKD).
Timeline
- Start
- 2009-09
- Primary completion
- 2010-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pirfenidone | Small molecule | 1200 mg | Oral |